Gene mutation may have effect on benefit of aspirin use for colorectal cancer

In two large studies, the association between aspirin use and risk of colorectal cancer was affected by mutation of the gene BRAF, with regular aspirin use associated with a lower risk of BRAF-wild-type colorectal cancer but not with risk of BRAF-mutated cancer, findings that suggest that BRAF-mutant colon tumor cells may be less sensitive to the effect of aspirin, according to a new study.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/W...

Gene mutation may have effect on benefit of aspirin use for colorectal cancer

{{date}} {{title}}